GGrantIndex
← Search

LAMIVUDINE PLUS STAVUDINE PLUS ABACAVIR PLUS AMPRENAVIR/RITONAVER

$22,974M01FY2004RRNIH

University Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

View original record on NIH RePORTER →
LAMIVUDINE PLUS STAVUDINE PLUS ABACAVIR PLUS AMPRENAVIR/RITONAVER · GrantIndex